C 404 (Tiagabine Hydrochloride 4 mg)

Pill with imprint C 404 is Yellow, Round and has been identified as Tiagabine Hydrochloride 4 mg. It is supplied by CIMA Laboratories, Inc.

Tiagabine is used in the treatment of epilepsy; seizures and belongs to the drug class gamma-aminobutyric acid reuptake inhibitors. Risk cannot be ruled out during pregnancy. Tiagabine 4 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C 404

Tiagabine Hydrochloride

Imprint: C 404
Strength: 4 mg
Color: Yellow
Shape: Round
Availability: Prescription only
Drug Class: Gamma-aminobutyric acid reuptake inhibitors
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: CIMA Laboratories, Inc.
Inactive Ingredients: ascorbic acid, silicon dioxide, hydrogenated soybean oil, hydroxypropyl cellulose, hypromelloses, lactose anhydrous, magnesium stearate, microcrystalline cellulose, corn starch, stearic acid, titanium dioxide, D&C Yellow No. 10
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
55253-0601 (Discontinued)
63459-0404 (Discontinued)	Cephalon, Inc.
00093-5031	Teva Pharmaceuticals USA, Inc.
52959-0684	H.J. Harkins Company, Inc. (repackager)
49999-0692	Lake Erie Medical and Surgical Supply (repackager)
68071-0312	Nucare Pharmaceuticals Inc. (repackager)
33261-0700	Aidarex Pharmacuticals, LLC (repackager)